- ¥900 - 1890
- 钰博生物
- 见说明书
- 德国/美国/中国
- YBEA041Hu
- 2026年10月26日
14 年钻石会员
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AI 赋能培养基定制开发：CHO 培养基是如何实现产量提升Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 库存：
1000
- 供应商：
上海钰博
- 检测范围：
见说明书
- 检测方法：
酶联免疫
- 应用：
科研
- 标记物：
见说明书
- 样本：
血清/组织/尿液
适用生物 Homo sapiens (Human，人)
中性粒细胞激活蛋白3(NAP3)检测试剂盒
检测范围 15.63-1000pg/mL 灵敏度 5.7pg/mL
样本类型 Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
实验时长 4.5h 实验方法 双抗夹心法
规格 96T
中性粒细胞激活蛋白3(NAP3)检测试剂盒
yb-E10036 人免疫球蛋白G Fc段受体Ⅲ(FcγRⅢ/CD16)ELISA试剂盒Segmentof human immunoglobulinG FcreceptorⅢ (FcγR Ⅲ / CD16) ELISAKit
yb-E10037 人免疫球蛋白G Fc段受体Ⅱ(FcγRⅡ/CD32)ELISA试剂盒Fc portionof human immunoglobulinGreceptorⅡ (FcγR Ⅱ / CD32) ELISAKit
yb-E10038 人免疫球蛋白G Fc段受体Ⅰ(FcγRⅠ/CD64)ELISA试剂盒Segmentof human immunoglobulinG FcreceptorⅠ (FcγR Ⅰ / CD64) ELISAKit
yb-E10039 人粒细胞趋化蛋白-2(GCP-2/CXCL6)ELISA试剂盒 Human granulocytechemotactic protein-2 (GCP-2/CXCL6) ELISAkit
yb-E10040 人糖基化依赖的细胞黏附分子(GlyCAM-1)ELISA试剂盒 Celladhesion moleculehuman glycosylation-dependent(GlyCAM-1) ELISAKit
yb-E10041 人干扰素调节因子(IRF)ELISA试剂盒Human interferonregulatory factor(IRF) ELISAkit
yb-E10042 人淋巴毒素α(LTA)ELISA试剂盒Human lymphotoxin α (LTA) ELISA kit
yb-E10043 人CC趋化因子受体1(CCR1)ELISA试剂盒Human CC chemokine receptor 1 (CCR1) ELISA kit
yb-E10044 人CX3C趋化因子受体1(CX3CR1)ELISA试剂盒 People CX3C chemokine receptor 1 (CX3CR1) ELISA kit
yb-E10045 人肺部活化调节趋化因子(PARC/CCL18)ELISA试剂盒Human pulmonary and activation-regulated chemokine (PARC/CCL18) ELISA kit
yb-E10046 人黏膜地址素细胞黏附分子(MAdCAM-1)ELISA试剂盒Human mucosal addressin cell adhesion molecule (MAdCAM-1) ELISA Kit
yb-E10047 人β干扰素(IFN-β/IFNB)ELISA试剂盒Human β interferon (IFN-β/IFNB) ELISA Kit
yb-E10048 人可溶性CD38(sCD38)ELISA试剂盒 Human soluble CD38 (sCD38) ELISA kit
yb-E10049 人可溶性CD21(CR2/sCD21)ELISA试剂盒Human soluble CD21 (CR2/sCD21) ELISA kit
yb-E10050 人可溶性瘦素受体(sLR)ELISA试剂盒Human soluble leptin receptor (sLR) ELISA kit
yb-E10051 人Toll样受体9(TLR-9/CD289)ELISA试剂Human Toll-like receptor 9 (TLR-9/CD289) ELISA kit
yb-E10052 人转化生长因子β2(TGFβ2)ELISA试剂盒Human transforming growth factor β2 (TGFβ2) ELISA kit
yb-E10053 人单核细胞趋化蛋白4(MCP-4/CCL13)ELISA试剂盒Human monocyte chemoattractant protein- 4 (MCP-4/CCL13) ELISA kit
yb-E10054 人白三烯D4(LTD4)ELISA试剂盒People leukotriene D4 (LTD4) ELISA kit
中性粒细胞激活蛋白3(NAP3)检测试剂盒
检测范围 15.63-1000pg/mL 灵敏度 5.7pg/mL
样本类型 Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
实验时长 4.5h 实验方法 双抗夹心法
规格 96T
中性粒细胞激活蛋白3(NAP3)检测试剂盒
ELISA Kit for Neutrophil Activating Protein 3 (NAP3)
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
| Organism species | Homo sapiens (Human) |
| Product No. | SEA041Hu |
| Sample type | Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
| Format | 96T |
| Assay length | 4.5 hours |
| Detection range | 15.63-1000pg/mL The standard curve concentrations used for the ELISA’s were 1000pg/mL, 500pg/mL, 250pg/mL, 125pg/mL, 62.5pg/mL, 31.25pg/mL, 15.63pg/mL |
| Sensitivity | The minimum detectable dose of this kit is typically less than 5.7pg/mL. |
Specificity
This assay has high sensitivity and excellent specificity for detection of Neutrophil Activating Protein 3 (NAP3).
No significant cross-reactivity or interference between Neutrophil Activating Protein 3 (NAP3) and analogues was observed.
No significant cross-reactivity or interference between Neutrophil Activating Protein 3 (NAP3) and analogues was observed.
Recovery
中性粒细胞激活蛋白3(NAP3)检测试剂盒Matrices listed below were spiked with certain level of recombinant Neutrophil Activating Protein 3 (NAP3) and the recovery rates were calculated by comparing the measured value to the expected amount of Neutrophil Activating Protein 3 (NAP3) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 97-105 | 101 |
| EDTA plasma(n=5) | 83-99 | 90 |
| heparin plasma(n=5) | 92-101 | 95 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Neutrophil Activating Protein 3 (NAP3) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Neutrophil Activating Protein 3 (NAP3) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Neutrophil Activating Protein 3 (NAP3) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Neutrophil Activating Protein 3 (NAP3) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 93-101% | 90-98% | 80-93% | 80-99% |
| EDTA plasma(n=5) | 82-98% | 85-96% | 89-96% | 90-104% |
| heparin plasma(n=5) | 89-105% | 80-102% | 97-105% | 80-92% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
| Standard | 2 | Standard Diluent | 1×20mL |
| Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
| Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
| TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
| Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 2 hours at 37oC;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37oC;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37oC;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 15-25 minutes at 37oC;
8. Add 50µL Stop Solution. Read at 450nm immediately.
2. Add 100µL standard or sample to each well. Incubate 2 hours at 37oC;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37oC;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37oC;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 15-25 minutes at 37oC;
8. Add 50µL Stop Solution. Read at 450nm immediately.
Test principle
中性粒细胞激活蛋白3(NAP3)检测试剂盒The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Neutrophil Activating Protein 3 (NAP3). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Neutrophil Activating Protein 3 (NAP3). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Neutrophil Activating Protein 3 (NAP3), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Neutrophil Activating Protein 3 (NAP3) in the samples is then determined by comparing the O.D. of the samples to the standard curve.
yb-E10035 人免疫球蛋白E Fc段受体Ⅱ(FcεRⅡ/CD23)ELISA试剂盒Segmentof human immunoglobulinE FcreceptorⅡ (FcεR Ⅱ / CD23) ELISAKit
yb-E10036 人免疫球蛋白G Fc段受体Ⅲ(FcγRⅢ/CD16)ELISA试剂盒Segmentof human immunoglobulinG FcreceptorⅢ (FcγR Ⅲ / CD16) ELISAKit
yb-E10037 人免疫球蛋白G Fc段受体Ⅱ(FcγRⅡ/CD32)ELISA试剂盒Fc portionof human immunoglobulinGreceptorⅡ (FcγR Ⅱ / CD32) ELISAKit
yb-E10038 人免疫球蛋白G Fc段受体Ⅰ(FcγRⅠ/CD64)ELISA试剂盒Segmentof human immunoglobulinG FcreceptorⅠ (FcγR Ⅰ / CD64) ELISAKit
yb-E10039 人粒细胞趋化蛋白-2(GCP-2/CXCL6)ELISA试剂盒 Human granulocytechemotactic protein-2 (GCP-2/CXCL6) ELISAkit
yb-E10040 人糖基化依赖的细胞黏附分子(GlyCAM-1)ELISA试剂盒 Celladhesion moleculehuman glycosylation-dependent(GlyCAM-1) ELISAKit
yb-E10041 人干扰素调节因子(IRF)ELISA试剂盒Human interferonregulatory factor(IRF) ELISAkit
yb-E10042 人淋巴毒素α(LTA)ELISA试剂盒Human lymphotoxin α (LTA) ELISA kit
yb-E10043 人CC趋化因子受体1(CCR1)ELISA试剂盒Human CC chemokine receptor 1 (CCR1) ELISA kit
yb-E10044 人CX3C趋化因子受体1(CX3CR1)ELISA试剂盒 People CX3C chemokine receptor 1 (CX3CR1) ELISA kit
yb-E10045 人肺部活化调节趋化因子(PARC/CCL18)ELISA试剂盒Human pulmonary and activation-regulated chemokine (PARC/CCL18) ELISA kit
yb-E10046 人黏膜地址素细胞黏附分子(MAdCAM-1)ELISA试剂盒Human mucosal addressin cell adhesion molecule (MAdCAM-1) ELISA Kit
yb-E10047 人β干扰素(IFN-β/IFNB)ELISA试剂盒Human β interferon (IFN-β/IFNB) ELISA Kit
yb-E10048 人可溶性CD38(sCD38)ELISA试剂盒 Human soluble CD38 (sCD38) ELISA kit
yb-E10049 人可溶性CD21(CR2/sCD21)ELISA试剂盒Human soluble CD21 (CR2/sCD21) ELISA kit
yb-E10050 人可溶性瘦素受体(sLR)ELISA试剂盒Human soluble leptin receptor (sLR) ELISA kit
yb-E10051 人Toll样受体9(TLR-9/CD289)ELISA试剂Human Toll-like receptor 9 (TLR-9/CD289) ELISA kit
yb-E10052 人转化生长因子β2(TGFβ2)ELISA试剂盒Human transforming growth factor β2 (TGFβ2) ELISA kit
yb-E10053 人单核细胞趋化蛋白4(MCP-4/CCL13)ELISA试剂盒Human monocyte chemoattractant protein- 4 (MCP-4/CCL13) ELISA kit
yb-E10054 人白三烯D4(LTD4)ELISA试剂盒People leukotriene D4 (LTD4) ELISA kit
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
WHO拉响警报：汉坦病毒邮轮疫情升级，从血管渗漏到细胞因子风暴，这篇讲透
器”的角色 [3]。 肿瘤坏死因子（TNF）：活化的中性粒细胞释放TNF-α，能够直接或通过介导其他炎症因子间接增强血管通透性，这是导致出血和休克的关键环节 趋化因子与生长因子：CCL-5（又称RANTES）和干细胞生长因子（SCGF）-b在致死病例中的水平也显著升高。 细胞因子并非凭空产生，它们的爆发式合成依赖于细胞内一系列信号通路的激活。如NF-κB通路、干扰素（IFN）信号通路、STING通路，VEGF信号通路。干预这些通路是控制细胞因子风暴的关键。汉坦病毒（Hantavirus）结构
Elabscience 巨噬细胞三大功能及检测方案全梳理，看完少走90%弯路！
免疫），也参与特异性免疫（细胞免疫）。它们有的固定驻扎，有的以游离形式四处巡视。一旦发现细胞碎片或入侵的病原体，便会迅速将其吞噬、消化。同时，巨噬细胞还能激活其他免疫细胞，促使机体产生精准的免疫应答。可以说，巨噬细胞绝不只是清理残骸的“清道夫”，它更像一位集侦察兵、指挥官于一体的免疫多面手。正因其功能如此丰富而关键，巨噬细胞也成为研究细胞吞噬、细胞免疫和分子免疫学的重要对象。 图1. 巨噬细胞的多面功能 二、吞噬功能——身体的“清道夫” 吞噬作用是吞噬和清除颗粒细胞或细胞碎片的过程，包括微生物、外来物质
显不适，可能仅有蛋白尿、夜尿增多或高血压；随着病情进展至CKD 3期及以上，可出现乏力、食欲下降、水肿、贫血等；晚期则表现为恶心、皮肤瘙痒、呼吸困难甚至尿毒症症状。因此，肾纤维化的识别依赖于尿检、血肌酐、eGFR等实验室指标及影像学或肾活检，而非主观症状，强调早筛早治的重要性。 肾纤维化机制 肾脏损伤可促使细胞外基质（ECM）过度生成并异常积聚，进而取代正常的肾功能单位，造成肾单位的不可逆丢失。肾单位（如肾小管或肾小球）受损后，触发局部炎症反应，募集巨噬细胞、中性粒细胞、淋巴细胞和肥大细胞，释放IL
技术资料暂无技术资料 索取技术资料
中性粒细胞激活蛋白3(NAP3)检测试剂盒
¥900 - 1890
